Vineet Laboratories Limited has deferred the consideration of its audited standalone financial results for the quarter and financial year ended March 31, 2026. The Board of Directors, which met on May 30, 2026, could not take up the approval of the results as the Audit Committee had not considered or recommended them. The company will intimate the revised dates for the Audit Committee and Board meetings to the stock exchanges in due course.

The Board was informed of the resignation of the Company Secretary and Compliance Officer during the meeting held on May 30, 2026. The deferment of the financial results means the trading window for dealing in the equity shares of the company will remain closed. The window, which shut on April 01, 2026, will reopen 48 hours after the declaration of the audited standalone financial results for the quarter and financial year ended March 31, 2026.

The proceedings are governed by the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the SEBI (Prohibition of Insider Trading) Regulations, 2015. The intimation regarding the deferment was submitted to BSE Limited and National Stock Exchange of India Limited on May 30, 2026. Gaddam Venkata Ramana, Managing Director, signed the disclosure.

Vineet Laboratories Limited announced that Mr. Ramesh Kumar Bandari has resigned from the post of Company Secretary and Compliance Officer effective May 29, 2026, due to personal reasons. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Consequently, Mr. Bandari has ceased to be Key Managerial Personnel under Section 203 of the Companies Act, 2013.

The resignation was communicated to the stock exchanges via a letter dated May 29, 2026. In his resignation letter, Mr. Bandari cited pre-occupation and personal obligations as the reasons for stepping down. He requested the Board to take the necessary steps, including intimating the Stock Exchanges and filing the required forms with the Registrar of Companies.

Details of the Change

The company provided the following details regarding the change in key managerial personnel as per Regulation 30 read with Schedule III of the Listing Regulations and SEBI Circular No. HO/49/14/14(7)2025-CFD-P0D2/I/3762/2026 dated January 30, 2026.

The filing was signed by Managing Director Gaddam Venkata Ramana on behalf of Vineet Laboratories Limited.